Scientists have found that a greater number of patients with coronary artery disease may benefit from coronary artery bypass graft (CABG) surgery than previously thought.
There were several trends seen in new cardiovascular technologies showcased on the expo floor at the 2016 American College of Cardiology (ACC) meeting in April. These insights are from clinical analysts from the evidence-based research and consulting company MD Buyline.
MD Buyline market analyst Jon Brubaker explained the new technology and trends he saw on the show floor at ACC.16.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Michael Jaff, M.D., medical director of Massachusetts General Hospital’s Fireman Vascular Center, explains the current ...
Healthcare institutions are trying to drive productivity by increasing patient throughput while still maintaining a ...
Medtronic plc announced new clinical data from one of the endpoints in the RevElution Trial for its novel, next-generation Drug-Filled Stent (DFS).
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
UltraSPECT Inc. announced the 10th anniversary of the U.S. Food and Drug Administration (FDA) approval of its Wide Beam Reconstruction (WBR) technology.
CS Medical announced the release of their newest product designed to aid in the circle of care for transesophageal echo (TEE) probes.
April 19, 2016 — Toshiba America Medical Systems Inc.’s Aquilion Lightning computed tomography (CT) system was U.S. Food ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Lowering cholesterol with statins significantly reduced adverse cardiovascular events in people with average cholesterol and blood pressure levels who were considered to be at intermediate risk for heart disease, according to a new study.
April 20, 2016 — A competition that used technology to encourage and track physical activity was effective at helping ...
April 20, 2016 — Boston Scientific Corp. announced a U.S. Food and Drug Administration (FDA) Class 1 recall of the Fetch ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
In the first large randomized trial to directly compare two approaches to preventing atrial fibrillation following heart surgery, controlling heart rate and controlling heart rhythm performed equally well.
The continuation of positive clinical trial data for transcatheter aortic valve repair (TAVR), showing it is equal to or ...
In one of the largest trials ever conducted of heart failure patients with reduced ejection fraction, the investigational drug aliskiren failed to show superiority over full-dose treatment with the existing “gold standard” therapy angiotensin-converting enzyme (ACE) inhibitor enalapril.